Clinical Trial Update: SRS for NSCLC With Oligo-residual Intracranial Disease After First-line 3rd Generation EGFR-TKI [Phase 2]

View source ↗

Summary

Clinical trial update on stereotactic radiosurgery for brain metastases in non-small cell lung cancer after a first-line third-generation EGFR-TKI; Phase 2, cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Snippet

Sponsor: Fudan University | Conditions: Brain Metastases, Non-small Cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING